are diagnosed as Covid-19 patients by positive PCR test or by CT Scan Exclusion criteria:pregnant and (...) with Covid-19 that will be Recipient of standard national protocol drugs + Vitamin C 500mg Control Group: Patients with Covid-19 that will be Recipient of standard national protocol drugs + placebo of

Study aim: The effect of naproxen on the healing process of COVID-19 patients Design: This double (...) : Inclusion criteria: COVID-19 patients that have positive PCR test of nasopharyngeal sample or have positive (...) with Covid 19 (improvement of fever, chills, cough and night sweats)

clinical trial. The study population includes all patients with COVID-19 referring to Abadan hospitals. All (...) severe symptoms of COVID-19 who were admitted to the infectious ward of Ayatollah Taleghani Hospital in (...) COVID-19 with severe symptoms and positive RT-PCR assay of nasopharyngeal samples Exclusion criteria

inflammatory biomarkers in patients with COVID-19 Design: Clinical trial with control group, with parallel (...) performed on 88 patients with Covid-19 referring to the clinic of Razi Hospital in Ahvaz. Patients are (...) . Participants/Inclusion and exclusion criteria: Patients aged 18 to 65 years Laboratory confirmation of Covid-19

Ayatollah Taleghani Hospital in Abadan. The study was performed on 100 patients with COVID-19 who were (...) Study aim: Comparison of the administration of vitamin D3 and N acetylcysteine tablets in COVID-19 (...) /Inclusion and exclusion criteria: Inclusion criteria: COVID-19 patients that have positive PCR test of

Study aim: Determination of the effect of sofosbuvir/daclatasvir in COVID-19 patients Design: A clinical trial with a, with parallel control group, double-blind, randomized, phase 3, and multicenter groups per 1000 patients. Settings and conduct: The study is a double-blind clinical trial. The sample